Sweden approves Sandoz’s Airflusal® Forspiro®
Holzkirchen, Germany, January 14, 2014 – Sandoz announced today it has received Swedish marketing authorization for AirFluSal® Forspiro®, an innovative new inhaler for patients with asthma and COPD.The product was first approved in Denmark on December …